Skip to main content
. 2020 Aug 27;11:537265. doi: 10.3389/fphar.2020.537265

Figure 8.

Figure 8

Survival of subpopulations was extremely similar when composite risk was low. In contrast, prognostic superiority of residual HER3 negative subpopulation was outstanding when composite risk rise, as their relapse free survival (>60%) was 40% more than HER3 positive cases (nearly 20%) when composite risk reached the highest point of 3.24.